Mission Statement
The Biotech Capital Group was formed in order to provide a resource for those emerging biotech companies who seek to alleviate some of the greatest challenges in medicine. The Biotech Capital Group pays particular attention to those companies engaging in oncological research utilizing stem cells or immunotherapy techniques. For us, meeting these challenges is personal. We firmly believe that achievements in scientific research can only lead to the betterment of society as a whole. The Biotech Capital Group considers it an honor and a privilege to work along side these biotech companies as they strive to make life better for us all.
Talent
The Biotech Capital Group derives its strength and reputation from its staff. Our members are highly talented, driven, successful industry professionals who are committed to nothing less than perfection. This is exhibited in the highly sophisticated work product our firm generates. Members of our staff have attended such prestigious institutions as Harvard University and the University of Wisconsin-Madison.
Other members of our team have engaged in scientific research at some of America's top research institutions. Particular areas of research involve the gene transduction of Th-1 and Th-2 Alpha and Beta chains in order to re-program T-cells in the treatment of Pancreatic Cancer.
